The interplay between the bone and the immune system

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Mori, Giorgio ^a   D'Amelio, Patrizia ^b   Faccio, Roberta ^c   Brunetti, Giacomina ^d  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; DECOY RECEPTOR 3; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 7; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

B LYMPHOCYTE; BONE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; DENDRITIC CELL; GAMMA DELTA T LYMPHOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; MACROPHAGE; MYELOID DENDRITIC CELL; MYELOID PROGENITOR CELL; NATURAL KILLER T CELL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE; TH17 CELL; ANIMAL; BONE DEVELOPMENT; IMMUNOLOGY; OSTEOCYTE; PHYSIOLOGY;

ANIMALS; BONE AND BONES; BONE RESORPTION; HUMANS; IMMUNE SYSTEM; OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES; OSTEOGENESIS;

EID: 84881507435     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/720504     Document Type: Review

References (210)

1. Knowles H. J., Athanasou N. A., Canonical and non-canonical pathways of osteoclast formation. Histology and Histopathology 2009 24 3 337 346 2-s2.0-63649146266
2. Long F., Building strong bones: molecular regulation of the osteoblast lineage. Nature Reviews Molecular Cell Biology 2012 13 1 27 38 2-s2.0-84255200563 10.1038/nrm3254
3. Walsh M. C., Kim N., Kadono Y., Rho J., Lee S. Y., Lorenzo J., Choi Y., Osteoimmunology: interplay between the immune system and bone metabolism. Annual Review of Immunology 2006 24 33 63 2-s2.0-33645657715 10.1146/annurev.immunol. 24.021605.090646
4. Sato K., Takayanagi H., Osteoclasts, rheumatoid arthritis, and osteoimmunology. Current Opinion in Rheumatology 2006 18 4 419 426 2-s2.0-33748032383 10.1097/01.bor.0000231912.24740.a5 (Pubitemid 44297289)
5. D'Amelio P., Isaia G. C., Immune system and postmenopausal bone loss. Clinical Reviews in Bone and Mineral Metabolism 2009 7 4 262 268 2-s2.0-70449526546 10.1007/s12018-009-9061-7
6. Yoshida H., Hayashi S.-I., Kunisada T., Ogawa M., Nishikawa S., Okumura H., Sudo T., Schultz L. D., Nishikawa S.-I., The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990 345 6274 442 443 2-s2.0-0025332897 10.1038/345442a0 (Pubitemid 20178250)
7. Faccio R., Takeshita S., Zallone A., Ross F. P., Teitelbaum S. L., c-Fms and the α v β 3 integrin collaborate during osteoclast differentiation. Journal of Clinical Investigation 2003 111 5 749 758 2-s2.0-0037332596 10.1172/JCI200316924 (Pubitemid 36278593)
8. Hofbauer L. C., Heufelder A. E., Role of receptor activator of nuclear factor- B ligand and osteoprotegerin in bone cell biology. Journal of Molecular Medicine 2001 79 5-6 243 253 2-s2.0-0034937704 10.1007/s001090100226 (Pubitemid 32646379)
9. D'Amelio P., Isaia G., Isaia G. C., The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. Journal of Endocrinological Investigation 2009 32 4 6 9 2-s2.0-77649228699
10. Xu J., Wu H. F., Ang E. S. M., Yip K., Woloszyn M., Zheng M. H., Tan R. X., NF- B modulators in osteolytic bone diseases. Cytokine and Growth Factor Reviews 2009 20 1 7 17 2-s2.0-60949083515 10.1016/j.cytogfr.2008.11.007
11. Grundt A., Grafe I. A., Liegibel U., Sommer U., Nawroth P., Kasperk C., Direct effects of osteoprotegerin on human bone cell metabolism. Biochemical and Biophysical Research Communications 2009 389 3 550 555 2-s2.0-70449726619 10.1016/j.bbrc.2009.09.026
12. D'Amelio P., Grimaldi A., Di Bella S., Brianza S. Z. M., Cristofaro M. A., Tamone C., Giribaldi G., Ulliers D., Pescarmona G. P., Isaia G., Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone 2008 43 1 92 100 2-s2.0-44949083462 10.1016/j.bone.2008.02.017
13. Leibbrandt A., Penninger J. M., RANK/RANKL: regulators of immune responses and bone physiology. Annals of the New York Academy of Sciences 2008 1143 123 150 2-s2.0-56549098575 10.1196/annals.1443.016
14. Fili S., Karalaki M., Schaller B., Mechanism of bone metastasis: the role of osteoprotegerin and of the host-tissue microenvironment-related survival factors. Cancer Letters 2009 283 1 10 19 2-s2.0-67650462567 10.1016/j.canlet. 2009.01.011
15. Charatcharoenwitthaya N., Khosla S., Atkinson E. J., McCready L. K., Riggs B. L., Effect of blockade of TNF- α and interleukin-1 action on bone resorption in early postmenopausal women. Journal of Bone and Mineral Research 2007 22 5 724 729 2-s2.0-34447303828 10.1359/jbmr.070207 (Pubitemid 351339101)
16. Roato I., Brunetti G., Gorassini E., Grano M., Colucci S., Bonello L., Buffoni L., Manfredi R., Ruffini E., Ottaviani D., Ciuffreda L., Mussa A., Ferracini R., IL-7 up-regulates TNF- α -dependent osteoclastogenesis in patients affected by solid tumor. PLoS ONE 2006 1 1, article e124 2-s2.0-35448982256 10.1371/journal.pone.0000124
17. D'Amelio P., Grimaldi A., Bernabei P., Pescarmona G. P., Isaia G., Immune system and bone metabolism: does thymectomy influence postmenopausal bone loss in humans? Bone 2006 39 3 658 665 2-s2.0-33746642148 10.1016/j.bone.2006.03.009 (Pubitemid 44149278)
18. Yao Z., Painter S. L., Fanslow W. C., Ulrich D., Macduff B. M., Spriggs M. K., Armitage R. J., Human IL-17: a novel cytokine derived from T cells. Journal of Immunology 1995 155 12 5483 5486 2-s2.0-0028858556
19. Lubberts E., Koenders M., van den Berg W. B., The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Research and Therapy 2005 7 1 29 37 2-s2.0-13444256307 10.1186/ar1478 (Pubitemid 40214525)
20. Yago T., Nanke Y., Kawamoto M., Furuya T., Kobashigawa T., Kamatani N., Kotake S., IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Research and Therapy 2007 9 5, article R96 2-s2.0-36448931232 10.1186/ar2297 (Pubitemid 350162912)
21. Quinn J. M. W., Sims N. A., Saleh H., Mirosa D., Thompson K., Bouralexis S., Walker E. C., Martin T. J., Gillespie M. T., IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in mice. Journal of Immunology 2008 181 8 5720 5729 2-s2.0-54049134748
22. Kalliolias G. D., Zhao B., Triantafyllopoulou A., Park-Min K.-H., Ivashkiv L. B., Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. Arthritis and Rheumatism 2010 62 2 402 413 2-s2.0-75749091859 10.1002/art.27200
23. Furukawa M., Takaishi H., Takito J., Yoda M., Sakai S., Hikata T., Hakozaki A., Uchikawa S., Matsumoto M., Chiba K., Kimura T., Okada Y., Matsuo K., Yoshida H., Toyama Y., IL-27 abrogates receptor activator of NF- B ligand-mediated osteoclastogenesis of human granulocyte-macrophage colony-forming unit cells through STAT1-dependent inhibition of c-Fos. Journal of Immunology 2009 183 4 2397 2406 2-s2.0-70149083341 10.4049/jimmunol.0802091
24. + T cells in part through STAT3. Immunology Letters 2011 138 1 47 53 2-s2.0-79957694768 10.1016/j.imlet.2011.02.022
25. Diveu C., McGeachy M. J., Boniface K., Stumhofer J. S., Sathe M., Joyce-Shaikh B., Chen Y., Tato C. M., McClanahan T. K., De Waal Malefyt R., Hunter C. A., Cua D. J., Kastelein R. A., IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. Journal of Immunology 2009 182 9 5748 5756 2-s2.0-66949157620 10.4049/jimmunol.0801162
26. Neufert C., Becker C., Wirtz S., Fantini M. C., Weigmann B., Galle P. R., Neurath M. F., IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. European Journal of Immunology 2007 37 7 1809 1816 2-s2.0-34447567140 10.1002/eji.200636896 (Pubitemid 47065120)
27. Roodman G. D., Perspectives: interleukin-6: an osteotropic factor? Journal of Bone and Mineral Research 1992 7 5 475 478 2-s2.0-0026863763
28. Takayanagi H., Ogasawara K., Hida S., Chiba T., Murata S., Sato K., Takaoka A., Yokochi T., Oda H., Tanaka K., Nakamura K., Taniguchi T., T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN- γ Nature 2000 408 6812 600 605 2-s2.0-0034735773 10.1038/35046102
29. Sato K., Satoh T., Shizume K., Yamakawa Y., Ono Y., Demura H., Akatsu T., Takahashi N., Suda T., Prolonged decrease of serum calcium concentration by murine γ -interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice. Cancer Research 1992 52 2 444 449 2-s2.0-0026512412
30. Massague J., The transforming growth factor- β family. Annual Review of Cell Biology 1990 6 597 641 2-s2.0-0025222517
31. Juárez P., Guise T. A., TGF- β in cancer and bone: implications for treatment of bone metastases. Bone 2011 48 1 23 29 2-s2.0-78650308466 10.1016/j.bone.2010.08.004
32. Gronthos S., Mankani M., Brahim J., Robey P. G., Shi S., Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 2000 97 25 13625 13630 2-s2.0-0034610376 10.1073/pnas.240309797
33. Mori G., Ballini A., Carbone C., Osteogenic differentiation of dental follicle stem cells. International Journal of Medical Science 2012 9 6 480 487
34. Mori G., Brunetti G., Oranger A., Carbone C., Ballini A., Muzio L. L., Colucci S., Mori C., Grassi F. R., Grano M., Dental pulp stem cells: osteogenic differentiation and gene expression. Annals of the New York Academy of Sciences 2011 1237 1 47 52 2-s2.0-81255176531 10.1111/j.1749-6632.2011.06234.x
35. Giorgini E., Conti C., Ferraris P., Sabbatini S., Tosi G., Centonze M., Grano M., Mori G., FT-IR microscopic analysis on human dental pulp stem cells. Vibrational Spectroscopy 2011 57 1 30 34 2-s2.0-84860392640 10.1016/j.vibspec. 2011.04.004
36. Mori G., Centonze M., Brunetti G., Ballini A., Oranger A., Mori C., Lo Muzio L., Tetè S., Ciccolella F., Colucci S., Grano M., Grassi F. R., Osteogenic properties of human dental pulp stem cells. Journal of Biological Regulators and Homeostatic Agents 2010 24 2 167 175 2-s2.0-77955904363
37. Morris D. C., Masuhara K., Takaoka K., Ono K., Anderson H. C., Immunolocalization of alkaline phosphatase in osteoblasts and matrix vesicles of human fetal bone. Bone and Mineral 1992 19 3 287 298 2-s2.0-0026457186 10.1016/0169-6009(92)90877-G
38. Mackie E. J., Osteoblasts: novel roles in orchestration of skeletal architecture. International Journal of Biochemistry and Cell Biology 2003 35 9 1301 1305 2-s2.0-0037706865 10.1016/S1357-2725(03)00107-9 (Pubitemid 36703168)
39. Anderson H. C., The role of matrix vesicles in physiological and pathological calcification. Current Opinion in Orthopaedics 2007 18 5 428 433 2-s2.0-34547906086 10.1097/BCO.0b013e3282e9ab49 (Pubitemid 47263009)
40. Yoshiko Y., Candeliere G. A., Maeda N., Aubin J. E., Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Molecular and Cellular Biology 2007 27 12 4465 4474 2-s2.0-34250197188 10.1128/MCB.00104-07 (Pubitemid 46906569)
41. Roberts S., Narisawa S., Harmey D., Millán J. L., Farquharson C., Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization. Journal of Bone and Mineral Research 2007 22 4 617 627 2-s2.0-34249687778 10.1359/jbmr.070108 (Pubitemid 47457439)
42. Hessle L., Johnson K. A., Anderson H. C., Narisawa S., Sali A., Goding J. W., Terkeltaub R., Millán J. L., Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proceedings of the National Academy of Sciences of the United States of America 2002 99 14 9445 9449 2-s2.0-0037047051 10.1073/pnas.142063399 (Pubitemid 34764633)
43. Rodan G. A., Martin T. J., Role of osteoblasts in hormonal control of bone resorption-a hypothesis. Calcified Tissue International 1981 33 4 349 351 2-s2.0-0019847761 (Pubitemid 12249943)
44. Silve C. M., Hradek G. T., Jones A. L., Arnaud C. D., Parathyroid hormone receptor in intact embryonic chicken bone: characterization and cellular localization. Journal of Cell Biology 1982 94 2 379 386 2-s2.0-0020320312 (Pubitemid 12026787)
45. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., Suda T., Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proceedings of the National Academy of Sciences of the United States of America 1998 95 7 3597 3602 2-s2.0-0032584208 10.1073/pnas.95.7.3597 (Pubitemid 28173173)
46. Tamma R., Colaianni G., Camerino C., Di Benedetto A., Greco G., Strippoli M., Vergari R., Grano A., Mancini L., Mori G., Colucci S., Grano M., Zallone A., Microgravity during spaceflight directly affects in vitro osteoclastogenesis and bone resorption. FASEB Journal 2009 23 8 2549 2554 2-s2.0-68849101656 10.1096/fj.08-127951
47. Chow J. W. M., Wilson A. J., Chambers T. J., Fox S. W., Mechanical loading stimulates bone formation by reactivation of bone lining cells in 13-week-old rats. Journal of Bone and Mineral Research 1998 13 11 1760 1767 2-s2.0-0031723256 10.1359/jbmr.1998.13.11.1760 (Pubitemid 28492007)
48. Forwood M. R., Owan I., Takano Y., Turner C. H., Increased bone formation in rat tibiae after a single short period of dynamic loading in vivo. American Journal of Physiology 1996 270 3 E419 E423 2-s2.0-0029919886
49. Noble B. S., Reeve J., Osteocyte function, osteocyte death and bone fracture resistance. Molecular and Cellular Endocrinology 2000 159 1-2 7 13 2-s2.0-0033977796 10.1016/S0303-7207(99)00174-4 (Pubitemid 30067635)
50. Pavalko F. M., Gerard R. L., Ponik S. M., Gallagher P. J., Jin Y., Norvell S. M., Fluid shear stress inhibits TNF- α -induced apoptosis in osteoblasts: a role for fluid shear stress-induced activation of PI3-kinase and inhibition of caspase-3. Journal of Cellular Physiology 2003 194 2 194 205 2-s2.0-0037294965 10.1002/jcp.10221 (Pubitemid 36043634)
51. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R. T., Gao Y.-H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T., Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997 89 5 755 764 2-s2.0-0030684749 (Pubitemid 27516178)
52. Ducy P., Zhang R., Geoffroy V., Ridall A. L., Karsenty G., Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997 89 5 747 754 2-s2.0-0030678549 (Pubitemid 27516177)
53. Lian J. B., Javed A., Zaidi S. K., Lengner C., Montecino M., Van Wijnen A. J., Stein J. L., Stein G. S., Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Critical Reviews in Eukaryotic Gene Expression 2004 14 1-2 1 41 2-s2.0-2342476573 (Pubitemid 38581526)
54. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., Amling M., Karsteny G., A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes and Development 1999 13 14 1025 1036 2-s2.0-0033565747 (Pubitemid 29200985)
55. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J. M., Behringer R. R., De Crombrugghe B., The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation. Cell 2002 108 1 17 29 2-s2.0-0037059614 10.1016/S0092-8674(01)00622-5 (Pubitemid 34137009)
56. Yang X., Matsuda K., Bialek P., Jacquot S., Masuoka H. C., Schinke T., Li L., Brancorsini S., Sassone-Corsi P., Townes T. M., Hanauer A., Karsenty G., ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology: implication for Coffin-Lowry syndrome. Cell 2004 117 3 387 398 2-s2.0-11144357428 10.1016/S0092-8674(04)00344-7 (Pubitemid 38534544)
57. Kassem M., Kveiborg M., Eriksen E. F., Production and action of transforming growth factor- β in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol. European Journal of Clinical Investigation 2000 30 5 429 437 2-s2.0-0034014914 10.1046/j.1365-2362.2000. 00645.x (Pubitemid 30251400)
58. Jilka R. L., Weinstein R. S., Bellido T., Parfitt A. M., Manolagas S. C., Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. Journal of Bone and Mineral Research 1998 13 5 793 802 2-s2.0-0031976864 10.1359/jbmr.1998.13.5.793 (Pubitemid 28224195)
59. Lucas P. A., Chemotactic response of osteoblast-like cells to transforming growth factor beta. Bone 1989 10 6 459 463 2-s2.0-0024947060 10.1016/8756-3282(89)90079-3 (Pubitemid 20114928)
60. Alliston T., Choy L., Ducy P., Karsenty G., Derynck R., TGF- β -induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO Journal 2001 20 9 2254 2272 2-s2.0-0035341209 10.1093/emboj/20.9.2254 (Pubitemid 32410595)
61. Maeda S., Hayashi M., Komiya S., Imamura T., Miyazono K., Endogenous TGF- β signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO Journal 2004 23 3 552 563 2-s2.0-1442313955 10.1038/sj.emboj.7600067 (Pubitemid 38282387)
62. Centrella M., Casinghino S., Kim J., Pham T., Rosen V., Wozney J., McCarthy T. L., Independent changes in type I and type II receptors for transforming growth factor β induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype. Molecular and Cellular Biology 1995 15 6 3273 3281 2-s2.0-0029033910
63. Canalis E., Economides A. N., Gazzerro E., Bone morphogenetic proteins, their antagonists, and the skeleton. Endocrine Reviews 2003 24 2 218 235 2-s2.0-0242668869 10.1210/er.2002-0023 (Pubitemid 36515285)
64. Spinella-Jaegle S., Roman-Roman S., Faucheu C., Dunn F.-W., Kawai S., Galléa S., Stiot V., Blanchet A. M., Courtois B., Baron R., Rawadi G., Opposite effects of bone morphogenetic protein-2 and transforming growth factor- β 1 on osteoblast differentiation. Bone 2001 29 4 323 330 2-s2.0-0034815142 10.1016/S8756-3282(01)00580-4 (Pubitemid 32930058)
65. Krishnan V., Bryant H. U., MacDougald O. A., Regulation of bone mass by Wnt signaling. Journal of Clinical Investigation 2006 116 5 1202 1209 2-s2.0-33646433058 10.1172/JCI28551
66. Baron R., Kneissel M., WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nature Medicine 2013 19 2 179 192
67. Baron R., Rawadi G., Wnt signaling and the regulation of bone mass. Current Osteoporosis Reports 2007 5 2 73 80 2-s2.0-34250752682 10.1007/s11914-007-0006-0 (Pubitemid 46954745)
68. Pinzone J. J., Hall B. M., Thudi N. K., Vonau M., Qiang Y.-W., Rosol T. J., Shaughnessy J. D. Jr., The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood 2009 113 3 517 525 2-s2.0-60249086335 10.1182/blood-2008-03-145169
69. Boyden L. M., Mao J., Belsky J., Mitzner L., Farhi A., Mitnick M. A., Wu D., Insogna K., Lifton R. P., High bone density due to a mutation in LDL-receptor-related protein 5. The New England Journal of Medicine 2002 346 20 1513 1521 2-s2.0-0037118285 10.1056/NEJMoa013444 (Pubitemid 34755690)
70. Gong Y., Slee R. B., Fukai N., LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001 107 4 513 523 (Pubitemid 33152786)
71. Ai M., Holmen S. L., Van Hul W., Williams B. O., Warman M. L., Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Molecular and Cellular Biology 2005 25 12 4946 4955 2-s2.0-20344398197 10.1128/MCB.25.12.4946-4955.2005 (Pubitemid 40781096)
72. Ellies D. L., Viviano B., McCarthy J., Rey J.-P., Itasaki N., Saunders S., Krumlauf R., Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. Journal of Bone and Mineral Research 2006 21 11 1738 1749 2-s2.0-33846449190 10.1359/jbmr.060810 (Pubitemid 46141229)
73. Balemans W., Ebeling M., Patel N., Van Hul E., Olson P., Dioszegi M., Lacza C., Wuyts W., Van Den Ende J., Willems P., Paes-Alves A. F., Hill S., Bueno M., Ramos F. J., Tacconi P., Dikkers F. G., Stratakis C., Lindpaintner K., Vickery B., Foernzler D., Van Hul W., Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Human Molecular Genetics 2001 10 5 537 543 2-s2.0-0035282968 (Pubitemid 32184286)
74. Balemans W., Patel N., Ebeling M., Van Hul E., Wuyts W., Lacza C., Dioszegi M., Dikkers F. G., Hildering P., Willems P. J., Verheij J. B. G. M., Lindpaintner K., Vickery B., Foernzler D., Van Hul W., Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. Journal of Medical Genetics 2002 39 2 91 97 2-s2.0-18244403197 (Pubitemid 34146376)
75. Tu X., Joeng K. S., Nakayama K. I., Nakayama K., Rajagopal J., Carroll T., McMahon A. P., Long F., Noncanonical Wnt signaling through G protein-linked PKC δ activation promotes bone formation. Developmental Cell 2007 12 1 113 127 2-s2.0-33845802651 10.1016/j.devcel.2006.11.003 (Pubitemid 46002598)
76. Takada I., Mihara M., Suzawa M., Ohtake F., Kobayashi S., Igarashi M., Youn M.-Y., Takeyama K.-I., Nakamura T., Mezaki Y., Takezawa S., Yogiashi Y., Kitagawa H., Yamada G., Takada S., Minami Y., Shibuya H., Matsumoto K., Kato S., A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR- γ transactivation. Nature Cell Biology 2007 9 11 1273 1285 2-s2.0-35748960839 10.1038/ncb1647 (Pubitemid 350042359)
77. Kneissel M., The promise of sclerostin inhibition for the treatment of osteoporosis. IBMS BoneKey 2009 6 259 264
78. Montero A., Okada Y., Tomita M., Ito M., Tsurukami H., Nakamura T., Doetschman T., Coffin J. D., Hurley M. M., Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. Journal of Clinical Investigation 2000 105 8 1085 1093 2-s2.0-0034007273 (Pubitemid 30217693)
79. Liu Z., Lavine K. J., Hung I. H., Ornitz D. M., FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. Developmental Biology 2007 302 1 80 91 2-s2.0-33846214070 10.1016/j.ydbio.2006.08.071 (Pubitemid 46096925)
80. Pan G., Ni J., Wei Y.-F., Yu G.-I., Gentz R., Dixit V. M., An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997 277 5327 815 818 2-s2.0-0030762815 10.1126/science.277.5327.815 (Pubitemid 27366732)
81. Sheridan J. P., Marsters S. A., Pitti R. M., Gurney A., Skubatch M., Baldwin D., Ramakrishnan L., Gray C. L., Baker K., Wood W. I., Goddard A. D., Godowski P., Ashkenazi A., Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997 277 5327 818 821 2-s2.0-0030792712 10.1126/science.277.5327.818 (Pubitemid 27366733)
82. Brunetti G., Oranger A., Carbone C., Osteoblasts display different responsiveness to TRAIL-Induced apoptosis during their differentiation process. Cell Biochemistry and Biophysics 2013 10.1007/s12013-013-9616-6
83. Mori G., Brunetti G., Colucci S., Ciccolella F., Coricciati M., Pignataro P., Oranger A., Ballini A., Farronato D., Mastrangelo F., Tetè S., Grassi F. R., Grano M., Alteration of activity and survival of osteoblasts obtained from human periodontitis patients: role of TRAIL. Journal of Biological Regulators and Homeostatic Agents 2007 21 3-4 105 114 2-s2.0-42149149379 (Pubitemid 351524044)
84. Mak T. W., Ferrick D. A., The γ δ T-cell bridge: linking innate and acquired immunity. Nature Medicine 1998 4 7 764 765 2-s2.0-0031593686 10.1038/nm0798-764 (Pubitemid 28331008)
85. Haas W., Pereira P., Tonegawa S., Gamma/delta cells. Annual Review of Immunology 1993 11 637 685 2-s2.0-0027512143 (Pubitemid 23115020)
86. Godfrey D. I., MacDonald H. R., Kronenberg M., Smyth M. J., Van Kaer L., NKT cells: what's in a name? Nature Reviews Immunology 2004 4 3 231 237 2-s2.0-1542511203 (Pubitemid 38339089)
87. Li Y., Toraldo G., Li A., Yang X., Zhang H., Qian W.-P., Weitzmann M. N., B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 2007 109 9 3839 3848 2-s2.0-34247323904 10.1182/blood-2006-07-037994 (Pubitemid 46641735)
88. Toraldo G., Roggia C., Qian W.-P., Pacific R., Weitzmann M. N., IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor B ligand and tumor necrosis factor α from T cells. Proceedings of the National Academy of Sciences of the United States of America 2003 100 1 125 130 2-s2.0-0037422560 10.1073/pnas.0136772100 (Pubitemid 36078040)
89. + T lymphocytes in osteoclast differentiation in vitro. Endocrinology 1996 137 6 2457 2463 2-s2.0-0029938143 10.1210/en.137.6.2457 (Pubitemid 26155782)
90. Grcevic D., Lee S.-K., Marusic A., Lorenzo J. A., Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis. Journal of Immunology 2000 165 8 4231 4238 2-s2.0-0034667933
91. Kung Y.-Y., Felge U., Sarosi I., Bolon B., Taturi A., Morony S., Capparelli C., Li J., Elliott R., McCabe S., Wong T., Campagnuolo G., Moran E., Bogoch E. R., Van G., Nguyen L. T., Ohashi P. S., Lacey D. L., Fish E., Boyle W. J., Penninger J. M., Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999 402 6759 304 309 2-s2.0-0033581952 10.1038/46303 (Pubitemid 129516268)
92. Colucci S., Brunetti G., Cantatore F. P., Oranger A., Mori G., Quarta L., Cirulli N., Mancini L., Corrado A., Grassi F. R., Grano M., Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNF α and IL-7 in an in vitro model derived from human psoriatic arthritis. Journal of Pathology 2007 212 1 47 55 2-s2.0-34248582794 10.1002/path.2153 (Pubitemid 46746289)
93. Teng Y.-T. A., Nguyen H., Gao X., Kong Y.-Y., Gorczynski R. M., Singh B., Ellen R. P., Penninger J. M., Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. Journal of Clinical Investigation 2000 106 6 R59 R67 2-s2.0-0033805254
94. Brunetti G., Colucci S., Pignataro P., Coricciati M., Mori G., Cirulli N., Zallone A., Grassi F. R., Grano M., T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients. Journal of Periodontology 2005 76 10 1675 1680 2-s2.0-27844548531 10.1902/jop.2005.76.10. 1675 (Pubitemid 41645576)
95. Colucci S., Brunetti G., Rizzi R., Zonno A., Mori G., Colaianni G., Del Prete D., Faccio R., Liso A., Capalbo S., Liso V., Zallone A., Grano M., T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction. Blood 2004 104 12 3722 3730 2-s2.0-9444231136 10.1182/blood-2004-02-0474 (Pubitemid 39564450)
96. Faienza M. F., Brunetti G., Colucci S., Piacente L., Ciccarelli M., Giordani L., Del Vecchio G. C., D'Amore M., Albanese L., Cavallo L., Grano M., Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor- B ligand/osteoprotegerin imbalance. Journal of Clinical Endocrinology and Metabolism 2009 94 7 2269 2276 2-s2.0-67650221408 10.1210/jc.2008-2446
97. Weitzmann M. N., Pacifici R., Estrogen deficiency and bone loss: an inflammatory tale. Journal of Clinical Investigation 2006 116 5 1186 1194 2-s2.0-33646396235 10.1172/JCI28550
98. Mosmann T. R., Cherwinski H., Bond M. W., Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology 1986 136 7 2348 2357 2-s2.0-0022640843 (Pubitemid 16136806)
99. Abbas A. K., Murphy K. M., Sher A., Functional diversity of helper T lymphocytes. Nature 1996 383 6603 787 793 2-s2.0-0029847368 10.1038/383787a0 (Pubitemid 26372655)
100. Mosmann T. R., Coffman R. L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology 1989 7 145 173 2-s2.0-0024353079 (Pubitemid 19138011)
101. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., Tanaka S., Kodama T., Akira S., Iwakura Y., Cua D. J., Takayanagi H., Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. Journal of Experimental Medicine 2006 203 12 2673 2682 2-s2.0-33751521013 10.1084/jem.20061775 (Pubitemid 44833343)
102. Harrington L. E., Mangan P. R., Weaver C. T., Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Current Opinion in Immunology 2006 18 3 349 356 2-s2.0-33646164439 10.1016/j.coi.2006.03.017
103. + T cells. Annual Review of Immunology 1994 12 635 673 2-s2.0-0028201726 (Pubitemid 24140427)
104. Bluestone J. A., Abbas A. K., Natural versus adaptive regulatory T cells. Nature Reviews Immunology 2003 3 3 253 257 2-s2.0-0037364804 10.1038/nri1032 (Pubitemid 37323210)
105. Reiner S. L., Development in motion: helper T cells at work. Cell 2007 129 1 33 36 2-s2.0-33947720523 10.1016/j.cell.2007.03.019 (Pubitemid 46507593)
106. Volpe E., Servant N., Zollinger R., Bogiatzi S. I., Hupé P., Barillot E., Soumelis V., A critical function for transforming growth factor- β interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nature Immunology 2008 9 6 650 657 2-s2.0-44049102724 10.1038/ni.1613 (Pubitemid 351712635)
107. Kotake S., Nanke Y., Mogi M., Kawamoto M., Furuya T., Yago T., Kobashigawa T., Togari A., Kamatani N., IFN- γ -producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL. European Journal of Immunology 2005 35 11 3353 3363 2-s2.0-27944457190 10.1002/eji.200526141 (Pubitemid 41672539)
108. Adamopoulos I. E., Bowman E. P., Immune regulation of bone loss by Th17 cells. Arthritis Research and Therapy 2008 10 5 225
109. Adamopoulos I. E., Chao C.-C., Geissler R., Laface D., Blumenschein W., Iwakura Y., McClanahan T., Bowman E. P., Interleukin-17A upregulates receptor activator of NF- B on osteoclast precursors. Arthritis Research and Therapy 2010 12 1, article R29 2-s2.0-77949454280 10.1186/ar2936
110. Noonan K., Marchionni L., Anderson J., Pardoll D., Roodman G. D., Borrello I., A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma. Blood 2010 116 18 3554 3563 2-s2.0-78149322663 10.1182/blood-2010-05-283895
111. Maddur M. S., Miossec P., Kaveri S. V., Bayry J., Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. American Journal of Pathology 2012 181 1 8 18
112. Zaiss M. M., Axmann R., Zwerina J., Polzer K., Gückel E., Skapenko A., Schulze-Koops H., Horwood N., Cope A., Schett G., Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis and Rheumatism 2007 56 12 4104 4112 2-s2.0-37149026641 10.1002/art.23138 (Pubitemid 350262338)
113. Zaiss M. M., Frey B., Hess A., Zwerina J., Luther J., Nimmerjahn F., Engelke K., Kollias G., Hünig T., Schett G., David J.-P., Regulatory T cells protect from local and systemic bone destruction in arthritis. Journal of Immunology 2010 184 12 7238 7246 2-s2.0-77953639101 10.4049/jimmunol.0903841
114. + regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis. Annals of the Rheumatic Diseases 2009 68 5 744 750 2-s2.0-66149146340 10.1136/ard.2007.086066
115. + regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochemical and Biophysical Research Communications 2007 357 4 1046 1052 2-s2.0-34247882571 10.1016/j.bbrc.2007.04.042 (Pubitemid 46693677)
116. Luo C. Y., Wang L., Sun C., Li D. J., Estrogen enhances the functions of CD4 CD25 Foxp3 regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro. Cellular and Molecular Immunology 2011 8 1 50 58 2-s2.0-79952467245 10.1038/cmi.2010.54
117. Wing K., Yamaguchi T., Sakaguchi S., Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation. Trends in Immunology 2011 32 9 428 433 2-s2.0-80051944092 10.1016/j.it.2011.06.002
118. Axmann R., Herman S., Zaiss M., Franz S., Polzer K., Zwerina J., Herrmann M., Smolen J., Schett G., CTLA-4 directly inhibits osteoclast formation. Annals of the Rheumatic Diseases 2008 67 11 1603 1609 2-s2.0-47249103596 10.1136/ard.2007.080713
119. + T cells. European Journal of Immunology 2001 31 7 2179 2188 (Pubitemid 32640735)
120. Terauchi M., Li J.-Y., Bedi B., Baek K.-H., Tawfeek H., Galley S., Gilbert L., Nanes M. S., Zayzafoon M., Guldberg R., Lamar D. L., Singer M. A., Lane T. F., Kronenberg H. M., Weitzmann M. N., Pacifici R., T Lymphocytes Amplify the Anabolic Activity of Parathyroid Hormone through Wnt10b Signaling. Cell Metabolism 2009 10 3 229 240 2-s2.0-69149106680 10.1016/j.cmet.2009.07.010
121. Bedi B., Li J.-Y., Tawfeek H., Baek K.-H., Adams J., Vangara S. S., Chang M.-K., Kneissel M., Weitzmann M. N., Pacifici R., Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH. Proceedings of the National Academy of Sciences of the United States of America
122. + T cells regulate bone tumor burden independent of osteoclast resorption. Cancer Research 2011 71 14 4799 4808 2-s2.0-79960414809 10.1158/0008-5472.CAN-10-3922
123. + T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology 2002 123 5 1516 1526 2-s2.0-0036828289 (Pubitemid 35231652)
124. + regulatory T cells: current controversies and future perspectives. European Journal of Immunology 2006 36 11 2832 2836 2-s2.0-33751231701 10.1002/eji.200636459 (Pubitemid 44782555)
125. + regulatory T cells in the lamina propria of patients with inflammatory bowel disease. Journal of Immunology 2005 174 9 5814 5822 2-s2.0-17844363998 (Pubitemid 40593226)
126. + regulatory T cells in multiple sclerosis. Annals of Neurology 2010 67 5 625 638 2-s2.0-77951712594 10.1002/ana.21944
127. Gavin M. A., Rasmussen J. P., Fontenot J. D., Vasta V., Manganiello V. C., Beavo J. A., Rudensky A. Y., Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007 445 7129 771 775 2-s2.0-33847153417 10.1038/nature05543 (Pubitemid 46279714)
128. + T regulatory cells. Current Opinion in Immunology 2008 20 3 327 331 2-s2.0-45449108015 10.1016/j.coi.2008.02.003
129. + T-cells suppress bone resorption in vitro. PLoS ONE 2012 7 6 e38199
130. Lanier L. L., NK cell recognition. Annual Review of Immunology 2005 23 225 274 2-s2.0-11144299492 10.1146/annurev.immunol.23.021704.115526 (Pubitemid 40563170)
131. Cooper M. A., Fehniger T. A., Turner S. C., Chen K. S., Ghaheri B. A., Ghayur T., Carson W. E., Caligiuri M. A., Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood 2001 97 10 3146 3151 2-s2.0-0035874522 10.1182/blood.V97.10.3146
132. Martín-Fontecha A., Thomsen L. L., Brett S., Gerard C., Lipp M., Lanzavecchia A., Sallusto F., Induced recruitment of NK cells to lymph nodes provides IFN- γ for TH1 priming. Nature Immunology 2004 5 12 1260 1265 2-s2.0-13444262764 10.1038/ni1138 (Pubitemid 41057741)
133. Wilder J. A., Koh C. Y., Yuan D., The role of NK cells during in vivo antigen-specific antibody responses. Journal of Immunology 1996 156 1 146 152 2-s2.0-0030024044 (Pubitemid 26006957)
134. Hu M., Bassett J. H. D., Danks L., Howell P. G. T., Spanoudakis E., Kotsianidis I., Boyde A., Williams G. R., Horwood N., Roberts I. A. G., Karadimitris A., Activated invariant NKT cells regulate osteoclast development and function. Journal of Immunology 2011 186 5 2910 2917 2-s2.0-79952761784 10.4049/jimmunol.1002353
135. de Matos C. T., Berq L., Michaëlsson J., Felländer-Tsai L., Kärre K., Söderström K., Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion. Immunology 2007 122 291 301 (Pubitemid 47389957)
136. Tak P. P., Kummer J. A., Hack C. E., Daha M. R., Smeets T. J. M., Erkelens G. W., Meinders A. E., Kluin P. M., Breedveld F. C., Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis and Rheumatism 1994 37 12 1735 1743 2-s2.0-0027997472 10.1002/art.1780371205 (Pubitemid 24371874)
137. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. Journal of Immunology 2001 166 11 6477 6482 2-s2.0-0035336402 (Pubitemid 32467184)
138. Dalbeth N., Gundle R., Davies R. J. O., Lee Y. C. G., McMichael A. J., Callan M. F. C., CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. Journal of Immunology 2004 173 10 6418 6426 2-s2.0-8444253252 (Pubitemid 39487802)
139. Zhang A. L., Colmenero P., Purath U., De Matos C. T., Hueber W., Klareskog L., Tarner I. H., Engleman E. G., Söderström K., Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood 2007 110 7 2484 2493 2-s2.0-34948832107 10.1182/blood-2007-02-076364 (Pubitemid 47523170)
140. Mcinnes I. B., Al-Mughales J., Field M., Leung B. P., Huang F.-P., Dixon R., Sturrock R. D., Wilkinson P. C., Liew F. Y., The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nature Medicine 1996 2 2 175 182 2-s2.0-0030022275 10.1038/nm0296-175 (Pubitemid 26057554)
141. Söderströma K., Stein E., Colmenero P., Purath U., Müller-Ladner U., De Matos C. T., Tarner I. H., Robinson W. H., Engleman E. G., Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proceedings of the National Academy of Sciences of the United States of America 2010 107 29 13028 13033 2-s2.0-77955612745 10.1073/pnas.1000546107
142. Hayday A. C., γ δ T Cells and the lymphoid stress-surveillance response. Immunity 2009 31 2 184 196 2-s2.0-68649104004 10.1016/j.immuni.2009.08.006
143. Tanaka Y., Morita C. T., Tanaka Y., Nieves E., Brenner M. B., Bloom B. R., Natural and synthetic non-peptide antigens recognized by human γ δ T cells. Nature 1995 375 6527 155 158 2-s2.0-0029073751
144. Strid J., Roberts S. J., Filler R. B., Lewis J. M., Kwong B. Y., Schpero W., Kaplan D. H., Hayday A. C., Girardi M., Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nature Immunology 2008 9 2 146 154 2-s2.0-38349191091 10.1038/ni1556
145. Kalyan S., Quabius E. S., Wiltfang J., Mönig H., Kabelitz D., Can peripheral blood γ δ T cells predict osteonecrosis of the jaw? An immunological perspective on the adverse drug-effects of aminobisphosphonate therapy. Journal of Bone and Mineral Research 2013 28 4 728 735 10.1002/jbmr.1769
146. Weitzmann M. N., Do gamma delta T-cells predict osteonecrosis of the jaw? Journal of Bone and Mineral Research 2013 28 723 727
147. Horowitz M. C., Fretz J. A., Lorenzo J. A., How B cells influence bone biology in health and disease. Bone 2010 47 3 472 479 2-s2.0-77955851132 10.1016/j.bone.2010.06.011
148. Choi Y., Woo K. M., Ko S. H., Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8 T cells. European Journal F Immunology 2001 31 2179 2188 (Pubitemid 32640735)
149. Manabe N., Kawaguchi H., Chikuda H., Miyaura C., Inada M., Nagai R., Nabeshima Y.-I., Nakamura K., Sinclair A. M., Scheuermann R. H., Kuro-o M., Connection between B lymphocyte and osteoclast differentiation pathways. Journal of Immunology 2001 167 5 2625 2631 2-s2.0-0035451466 (Pubitemid 32768891)
150. Colucci S., Mori G., Brunetti G., Coricciati M., Pignataro P., Oranger A., Cirulli N., Mastrangelo F., Grassi F. R., Grano M., Interleukin-7 production by B lymphocytes affects the T cell-dependent osteoclast formation in an in vitro model derived from human periodontitis patients. International Journal of Immunopathology and Pharmacology 2005 18 3 13 19 2-s2.0-34248533269
151. Oranger A., Carbone C., Izzo M., Grano M., Cellular mechanisms of multiple myeloma bone disease. Clinical and Developmental Immunology 2013 2013 11 289458 10.1155/2013/289458
152. Heider U., Langelotz C., Jakob C., Zavrski I., Fleissner C., Eucker J., Possinger K., Hofbauer L. C., Sezer O., Expression of receptor activator of nuclear factor B ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma. Clinical Cancer Research 2003 9 4 1436 1440 2-s2.0-0037389602 (Pubitemid 36418398)
153. Colucci S., Brunetti G., Mori G., Oranger A., Centonze M., Mori C., Cantatore F. P., Tamma R., Rizzi R., Liso V., Zallone A., Grano M., Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients. Leukemia 2009 23 11 2139 2146 2-s2.0-70450240910 10.1038/leu.2009.136
154. Giuliani N., Colla S., Sala R., Moroni M., Lazzaretti M., La Monica S., Bonomini S., Hojden M., Sammarelli G., Barillè S., Bataille R., Rizzoli V., Human myeloma cells stimulate the receptor activator of nuclear factor- B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. Blood 2002 100 13 4615 4621 2-s2.0-0037114636 10.1182/blood-2002-04- 1121 (Pubitemid 35429706)
155. Giuliani N., Colla S., Morandi F., Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation. Blood 2005 106 2472 2483 (Pubitemid 41510822)
156. Miyaura C., Onoe Y., Inada M., Maki K., Ikuta K., Ito M., Suda T., Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proceedings of the National Academy of Sciences of the United States of America 1997 94 17 9360 9365 2-s2.0-0030875168 10.1073/pnas.94.17.9360 (Pubitemid 27357834)
157. Colucci S., Brunetti G., Oranger A., Myeloma cells suppress osteoblasts through sclerostin secretion. Blood Cancer Journal 2011 1 6, article e27
158. Brunetti G., Oranger A., Mori G., Specchia G., Rinaldi E., Curci P., Zallone A., Rizzi R., Grano M., Colucci S., Sclerostin is overexpressed by plasma cells from multiple myeloma patients. Annals of the New York Academy of Sciences 2011 1237 1 19 23 2-s2.0-81255210568 10.1111/j.1749-6632.2011.06196.x
159. Masuzawa T., Miyaura C., Onoe Y., Kusano K., Ohta H., Nozawa S., Suda T., Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. Journal of Clinical Investigation 1994 94 3 1090 1097 2-s2.0-0028070867 (Pubitemid 24286451)
160. Erlandsson M. C., Jonsson C. A., Islander U., Ohlsson C., Carlsten H., Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice. Immunology 2003 108 3 346 351 2-s2.0-0037342558 10.1046/j.1365-2567.2003.01599.x (Pubitemid 36332393)
161. + cells: its role in accelerated osteoclastogenesis due to estrogen deficiency. Journal of Bone and Mineral Research 2001 16 12 2215 2221 2-s2.0-0035192371 (Pubitemid 33104711)
162. Kanematsu M., Sato T., Takai H., Watanabe K., Ikeda K., Yamada Y., Prostaglandin E2 induces expression of receptor activator of nuclear factor- B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. Journal of Bone and Mineral Research 2000 15 7 1321 1329 2-s2.0-0033623876 (Pubitemid 30413864)
163. Eghbali-Fatourechi G., Khosla S., Sanyal A., Boyle W. J., Lacey D. L., Riggs B. L., Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. Journal of Clinical Investigation 2003 111 8 1221 1230 2-s2.0-0037398261 10.1172/JCI200317215 (Pubitemid 36519939)
164. Weitzmann M. N., Cenci S., Haug J., Brown C., Di Persio J., Pacifici R., B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta. Journal of Cellular Biochemistry 2000 78 318 324 (Pubitemid 30415907)
165. Chenu C., Pfeilschifter J., Mundy G. R., Roodman G. D., Transforming growth factor β inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proceedings of the National Academy of Sciences of the United States of America 1988 85 15 5683 5687 2-s2.0-1542792344
166. Hughes D. E., Dai A., Tiffee J. C., Li H. H., Munoy G. R., Boyce B. F., Estrogen promotes apoptosis of murine osteoclasts mediated by TGF- β Nature Medicine 1996 2 10 1132 1135 2-s2.0-0029798819 10.1038/nm1096-1132 (Pubitemid 26338639)
167. Thirunavukkarasu K., Miles R. R., Halladay D. L., Yang X., Galvin R. J. S., Chandrasekhar S., Martin T. J., Onyia J. E., Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor- β (TGF- β). Mapping of the OPG promoter region that mediates TGF- β effects. Journal of Biological Chemistry 2001 276 39 36241 36250 2-s2.0-0035965326 10.1074/jbc.M104319200
168. Klausen B., Hougen H. P., Fiehn N. E., Increased periodontal bone loss in temporarily B lymphocyte-deficient rats. Journal of Periodontal Research 1989 24 6 384 390 2-s2.0-0024836275 (Pubitemid 20051047)
169. Onal M., Xiong J., Chen X., Receptor activator of nuclear factor kappaB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. The Journal of Biological Chemistry 2012 287 29851 29860
170. Manabe N., Kawaguchi H., Chikuda H., Miyaura C., Inada M., Nagai R., Nabeshima Y.-I., Nakamura K., Sinclair A. M., Scheuermann R. H., Kuro-o M., Connection between B lymphocyte and osteoclast differentiation pathways. Journal of Immunology 2001 167 5 2625 2631 2-s2.0-0035451466 (Pubitemid 32768891)
171. Kawai T., Matsuyama T., Hosokawa Y., Makihira S., Seki M., Karimbux N. Y., Goncalves R. B., Valverde P., Dibart S., Li Y.-P., Miranda L. A., Ernst C. W. O., Izumi Y., Taubman M. A., B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. American Journal of Pathology 2006 169 3 987 998 2-s2.0-33748788554 10.2353/ajpath.2006.060180 (Pubitemid 44411961)
172. Kanematsu M., Sato T., Takai H., Watanabe K., Ikeda K., Yamada Y., Prostaglandin E2 induces expression of receptor activator of nuclear factor- B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. Journal of Bone and Mineral Research 2000 15 7 1321 1329 2-s2.0-0033623876 (Pubitemid 30413864)
173. Vikulina T., Fan X., Yamaguchi M., Roser-Page S., Zayzafoon M., Guidot D. M., Ofotokun I., Weitzmann M. N., Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats. Proceedings of the National Academy of Sciences of the United States of America 2010 107 31 13848 13853 2-s2.0-77956378534 10.1073/pnas.1003020107
174. Choi Y., Kim J. J., B cells activated in the presence of Th1 cytokines inhibit osteoclastogenesis. Experimental and Molecular Medicine 2003 35 5 385 392 2-s2.0-0344441850 (Pubitemid 37474471)
175. Yun T. J., Chaudhary P. M., Shu G. L., Kimble Frazer J., Ewings M. K., Schwartz S. M., Pascual V., Hood L. E., Clark E. A., OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. Journal of Immunology 1998 161 11 6113 6121 2-s2.0-0032400933 (Pubitemid 28535982)
176. Grewal I. S., Flavell R. A., CD40 and CD154 in cell-mediated immunity. Annual Review of Immunology 1998 16 111 135 2-s2.0-0031944607 10.1146/annurev.immunol.16.1.111 (Pubitemid 28183361)
177. Wüthrich M., Fisette P. L., Filutowicz H. I., Klein B. S., Differential requirements of T cell subsets for CD40 costimulation in immunity to Blastomyces dermatitidis. Journal of Immunology 2006 176 9 5538 5547 2-s2.0-33645990300
178. Collin M., McGovern N., Haniffa M., Human dendritic cell subsets. Immunology 2013 10.1111/imm.12117
179. Steinman R. M., Banchereau J., Taking dendritic cells into medicine. Nature 2007 449 7161 419 426 2-s2.0-34848837386 10.1038/nature06175 (Pubitemid 47509552)
180. McKenna H. J., Stocking K. L., Miller R. E., Brasel K., De Smedt T., Maraskovsky E., Maliszewski C. R., Lynch D. H., Smith J., Pulendran B., Roux E. R., Teepe M., Lyman S. D., Peschon J. J., Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000 95 11 3489 3497 2-s2.0-0034210658 (Pubitemid 30428482)
181. Cirrincione C., Pimpinelli N., Orlando L., Romagnoli P., Lamina propria dendritic cells express activation markers and contact lymphocytes in chronic periodontitis. Journal of Periodontology 2002 73 1 45 52 2-s2.0-0036196054 10.1902/jop.2002.73.1.45 (Pubitemid 34213458)
182. Highton J., Kean A., Hessian P. A., Thomson J., Rietveld J., Hart D. N. J., Cells expressing dendritic cell markers are present in the rheumatoid nodule. Journal of Rheumatology 2000 27 2 339 346 2-s2.0-0033962722 (Pubitemid 30095461)
183. Thomas R., MacDonald K. P. A., Pettit A. R., Cavanagh L. L., Padmanabha J., Zehntner S., Dendritic cells and the pathogenesis of rheumatoid arthritis. Journal of Leukocyte Biology 1999 66 2 286 292 2-s2.0-0032776916 (Pubitemid 29379170)
184. Page G., Lebecque S., Miossec P., Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. Journal of Immunology 2002 168 10 5333 5341 2-s2.0-0037093852 (Pubitemid 34496002)
185. Page G., Miossec P., RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes. Arthritis and Rheumatism 2005 52 8 2307 2312 2-s2.0-23644450623 10.1002/art.21211 (Pubitemid 41117414)
186. Cutler C. W., Jotwani R., Dendritic cells at the oral mucosal interface. Journal of Dental Research 2006 85 8 678 689 2-s2.0-33748064978 10.1177/154405910608500801 (Pubitemid 44297321)
187. Santiago-Schwarz F., Anand P., Liu S., Carsons S. E., Dendritic cells (DCs) in rheumatoid arthritis (RA): progenitor cells and soluble factors contained in RA synovial fluid yield a subset of myeloid DCs that preferentially activate Th1 inflammatory-type responses. Journal of Immunology 2001 167 3 1758 1768 2-s2.0-0035424679 (Pubitemid 32703180)
188. Rivollier A., Mazzorana M., Tebib J., Piperno M., Aitsiselmi T., Rabourdin-Combe C., Jurdic P., Servet-Delprat C., Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 2004 104 13 4029 4037 2-s2.0-10244259169 10.1182/blood-2004-01-0041 (Pubitemid 39620153)
189. Teitelbaum S. L., Ross F. P., Genetic regulation of osteoclast development and function. Nature Reviews Genetics 2003 4 8 638 649 2-s2.0-0043267732 10.1038/nrg1122 (Pubitemid 36917505)
190. Schuler G., Lutz M. B., Bender A., Lotze M. T., Thomson A. W., A guide to the isolation and propagation of dendritic cells. Dendritic Cells: Biology and Clinical Applications 1999 San Diego, Calif, USA Academic Press 515 533
191. + dendritic cells. Journal of Immunology 2006 177 5 3314 3326 2-s2.0-33747748774 (Pubitemid 44277851)
192. Chauhan D., Singh A. V., Brahmandam M., Carrasco R., Bandi M., Hideshima T., Bianchi G., Podar K., Tai Y.-T., Mitsiades C., Raje N., Jaye D. L., Kumar S. K., Richardson P., Munshi N., Anderson K. C., Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target. Cancer Cell 2009 16 4 309 323 2-s2.0-70349577375 10.1016/j.ccr.2009.08.019
193. Kukreja A., Radfar S., Sun B.-H., Insogna K., Dhodapkar M. V., Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease. Blood 2009 114 16 3413 3421 2-s2.0-70350710809 10.1182/blood-2009-03-211920
194. Tucci M., Stucci S., Strippoli S., Dammacco F., Silvestris F., Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression? Oncologist 2011 16 7 1040 1048 2-s2.0-79960880111 10.1634/theoncologist.2010-0327
195. Dhodapkar K. M., Barbuto S., Matthews P., Kukreja A., Mazumder A., Vesole D., Jagannath S., Dhodapkar M. V., Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma. Blood 2008 112 7 2878 2885 2-s2.0-53449089919 10.1182/blood-2008-03-143222
196. Jacobs L., Nawrot T. S., De Geus B., Meeusen R., Degraeuwe B., Bernard A., Sughis M., Nemery B., Panis L. I., Subclinical responses in healthy cyclists briefly exposed to traffic-related air pollution: an intervention study. Environmental Health 2010 9 1, article 64 2-s2.0-77958121233 10.1186/1476-069X-9-64
197. Waugh D. J. J., Wilson C., The interleukin-8 pathway in cancer. Clinical Cancer Research 2008 14 21 6735 6741 2-s2.0-58149232586 10.1158/1078-0432.CCR- 07-4843
198. De Larco J. E., Wuertz B. R. K., Furcht L. T., The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clinical Cancer Research 2004 10 15 4895 4900 2-s2.0-4143050218 10.1158/1078-0432.CCR-03-0760 (Pubitemid 39099762)
199. Kantarci A., Oyaizu K., Van Dyke T. E., Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. Journal of Periodontology 2003 74 1 66 75 2-s2.0-0037266312 10.1902/jop.2003.74.1.66 (Pubitemid 36181488)
200. Hasturk H., Kantarci A., Ohira T., Arita M., Ebrahimi N., Chiang N., Petasis N. A., Levy B. D., Serhan C. N., Van Dyke T. E., RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB Journal 2006 20 2 401 403 2-s2.0-33644928418 10.1096/fj.05-4724fje (Pubitemid 46671185)
201. Tanaka D., Kagari T., Doi H., Shimozato T., Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology 2006 119 2 195 202 2-s2.0-33748751857 10.1111/j.1365-2567.2006.02424. x (Pubitemid 44401638)
202. Wipke B. T., Allen P. M., Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. Journal of Immunology 2001 167 3 1601 1608 2-s2.0-0035423403 (Pubitemid 32703161)
203. Chen M., Lam B. K., Kanaoka Y., Nigrovic P. A., Audoly L. P., Austen K. F., Lee D. M., Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. Journal of Experimental Medicine 2006 203 4 837 842 2-s2.0-33645859047 10.1084/jem.20052371
204. Edwards S. W., Hallett M. B., Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunology Today 1997 18 7 320 324 2-s2.0-0030737716 10.1016/S0167-5699(97)01087-6 (Pubitemid 27314467)
205. Poubelle P. E., Chakravarti A., Fernandes M. J., Doiron K., Marceau A.-A., Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils. Arthritis Research and Therapy 2007 9, article R25 2-s2.0-34047102471 10.1186/ar2137
206. Chakravarti A., Raquil M.-A., Tessier P., Poubelle P. E., Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption. Blood 2009 114 8 1633 1644 2-s2.0-70349565586 10.1182/blood-2008- 09-178301
207. Walsh N. C., Alexander K. A., Manning C. A., Activated human T cells express alternative mRNA transcripts encoding a secreted form of RANKL. Genes and Immunity 2013 10.1038/gene.2013.29
208. Kanamaru F., Iwai H., Ikeda T., Nakajima A., Ishikawa I., Azuma M., Expression of membrane-bound and soluble receptor activator of NF- B ligand (RANKL) in human T cells. Immunology Letters 2004 94 3 239 246 2-s2.0-3242731212 10.1016/j.imlet.2004.05.010 (Pubitemid 38953425)
209. Brunetti G., Faienza M. F., Piacente L., High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment. American Journal of Physiology, Endocrinology and Metabolism 2013 304 E546 E554
210. Allaeys I., Rusu D., Picard S., Pouliot M., Borgeat P., Poubelle P. E., Osteoblast retraction induced by adherent neutrophils promotes osteoclast bone resorption: implication for altered bone remodeling in chronic gout. Laboratory Investigation 2011 91 6 905 920 2-s2.0-79957616894 10.1038/labinvest.2011.46